Phase I and pharmacokinetic study of low-dose, three-times daily oral etoposide in patients with refractory solid tumors

被引：0
|
作者：
Schwartsmann, G
Di Leone, L
Caldas, APF
Campos, O
Cancela, AI
Viegas, MAV
Mans, DRA
机构：
[1] UFRGS, HCPA, S Amer Off Anticanc Drug Dev SOAD, Porto Alegre, RS, Brazil
[2] ULBRA, Lutheran Hosp, Porto Alegre, RS, Brazil
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
660
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Phase I and pharmacokinetic study of low-dose, three-times daily oral etoposide in patients with refractory solid tumors
    Schwartsmann, G
    Di Leone, L
    Caldas, APF
    Campos, O
    Viegas, MAV
    Cancela, AI
    Sander, E
    Ferreira, F
    Schunemann, H
    Mans, DRA
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1481 - 1482
  • [2] Phase I and pharmacokinetic study of oral etoposide given three-times daily orally to patients with refractory solid tumors
    Schwartsmann, G
    Mans, DRA
    Di Leone, L
    Caldas, APF
    Campos, O
    Sander, E
    Bortolini, M
    Viegas, MAV
    Cancela, AI
    ANNALS OF ONCOLOGY, 1998, 9 : 66 - 66
  • [3] Phase I Study of Three-Times Daily Oral Etoposide in Patients with Refractory Solid Tumours
    G. Schwartsmann
    A. P. F. Caldas
    T. Dalla Costa
    L. Di Leone
    O. Campos Junior
    A. Cancela
    H. Schunemann
    A. F. Ferreira Filho
    E. Sander
    D. R. A. Mans
    Clinical Drug Investigation, 2000, 19 : 375 - 383
  • [4] Phase I study of three-times daily oral etoposide in patients with refractory solid tumours
    Schwartsmann, G
    Caldas, APF
    Dalla Costa, T
    Di Leone, L
    Campos, O
    Cancela, A
    Schunemann, H
    Ferreira, AF
    Sander, E
    Mans, DRA
    CLINICAL DRUG INVESTIGATION, 2000, 19 (05) : 375 - 383
  • [5] PHASE-I STUDY OF ORAL ETOPOSIDE IN CHILDREN WITH REFRACTORY SOLID TUMORS
    MATHEW, P
    RIBEIRO, RC
    SONNICHSEN, D
    RELLING, M
    PRATT, C
    MAHMOUD, H
    BOWMAN, L
    MEYER, W
    AVERY, L
    CRIST, W
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) : 1452 - 1457
  • [6] Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors
    Grem, JL
    Harold, N
    Shapiro, J
    Bi, DQ
    Quinn, MG
    Zentko, S
    Keith, B
    Hamilton, JM
    Monahan, BP
    Donavan, S
    Grollman, F
    Morrison, G
    Takimoto, CH
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3952 - 3963
  • [7] Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors
    R. C. Brennan
    W. Furman
    S. Mao
    J. Wu
    D. C. Turner
    C. F. Stewart
    V. Santana
    L. M. McGregor
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1191 - 1198
  • [8] Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors
    Brennan, R. C.
    Furman, W.
    Mao, S.
    Wu, J.
    Turner, D. C.
    Stewart, C. F.
    Santana, V.
    McGregor, L. M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1191 - 1198
  • [9] A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors
    Fury, Matthew G.
    Sherman, Eric
    Haque, Sowa
    Korte, Susan
    Lisa, Donna
    Shen, Ronglai
    Wu, Nian
    Pfister, David
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 591 - 598
  • [10] A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors
    Matthew G. Fury
    Eric Sherman
    Sofia Haque
    Susan Korte
    Donna Lisa
    Ronglai Shen
    Nian Wu
    David Pfister
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 591 - 598
12345